BioNTech SE Current Tax Relating To Items Charged Or Credited Directly To Equity
BioNTech SE (BNTX) reported Current Tax Relating To Items Charged Or Credited Directly To Equity of EUR 368.80 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-27.
Discontinued › Operating Expenses
ifrs-full:CurrentTaxRelatingToItemsChargedOrCreditedDirectlyToEquity · last filed 2023-03-27
| Period end | Current Tax Relating To Items Charged Or Credited Directly To Equity 12 month |
|---|---|
| 2022-12-31 | 368.80M EUR 20-F · filed 2023-03-27 |